Gui-Bin Liang

534 total citations
23 papers, 305 citations indexed

About

Gui-Bin Liang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Gui-Bin Liang has authored 23 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Gui-Bin Liang's work include Bioactive Compounds and Antitumor Agents (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Respiratory Support and Mechanisms (3 papers). Gui-Bin Liang is often cited by papers focused on Bioactive Compounds and Antitumor Agents (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Respiratory Support and Mechanisms (3 papers). Gui-Bin Liang collaborates with scholars based in China, United States and United Kingdom. Gui-Bin Liang's co-authors include Zhihui He, Ri-Zhen Huang, Ye Zhang, Heng‐Shan Wang, Jian-Hua Wei, Xiaochao Huang, Yilin Fang, Zhi‐Xin Liao, Meimei Zhou and Zhen‐Feng Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Frontiers in Immunology.

In The Last Decade

Gui-Bin Liang

21 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gui-Bin Liang China 12 162 109 50 49 33 23 305
Maria Letícia de Castro Barbosa Brazil 9 161 1.0× 172 1.6× 29 0.6× 70 1.4× 19 0.6× 23 358
Altaf Ahmad Shah India 6 102 0.6× 62 0.6× 80 1.6× 43 0.9× 20 0.6× 11 442
Mervat M. Omran Egypt 12 113 0.7× 93 0.9× 40 0.8× 51 1.0× 6 0.2× 42 365
Jinlian Wei China 13 164 1.0× 117 1.1× 13 0.3× 50 1.0× 16 0.5× 27 345
Mandava Bhuvan Tej India 9 115 0.7× 151 1.4× 28 0.6× 40 0.8× 15 0.5× 18 303
Yasumasa Sugita Japan 10 97 0.6× 72 0.7× 14 0.3× 37 0.8× 25 0.8× 27 294
Isabelle Solassol France 10 103 0.6× 36 0.3× 50 1.0× 84 1.7× 12 0.4× 17 328
Wen Sheng Tzeng Taiwan 9 93 0.6× 88 0.8× 64 1.3× 46 0.9× 15 0.5× 19 372
Jinxia Zhang China 9 83 0.5× 139 1.3× 77 1.5× 133 2.7× 11 0.3× 19 409
Venkataraman Srinivasan United States 11 149 0.9× 57 0.5× 107 2.1× 47 1.0× 27 0.8× 19 534

Countries citing papers authored by Gui-Bin Liang

Since Specialization
Citations

This map shows the geographic impact of Gui-Bin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui-Bin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui-Bin Liang more than expected).

Fields of papers citing papers by Gui-Bin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gui-Bin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui-Bin Liang. The network helps show where Gui-Bin Liang may publish in the future.

Co-authorship network of co-authors of Gui-Bin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Gui-Bin Liang. A scholar is included among the top collaborators of Gui-Bin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gui-Bin Liang. Gui-Bin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Gui-Bin, et al.. (2024). Macrophages-derived high-mobility group box-1 protein induces endothelial progenitor cells pyroptosis. iScience. 27(10). 110996–110996. 1 indexed citations
2.
Liang, Simin, Gui-Bin Liang, Huiling Wang, et al.. (2023). Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance. European Journal of Medicinal Chemistry. 263. 115937–115937. 14 indexed citations
3.
4.
Liang, Gui-Bin & Zhihui He. (2023). MicroRNAs in Sepsis-Induced Acute Lung Injury: New Advances in Diagnostics and Therapeutic. SHILAP Revista de lepidopterología. 3(2). 150–155.
5.
Liang, Gui-Bin, et al.. (2023). Cigarette smoke extract induces the senescence of endothelialprogenitor cells by upregulating p300. Tobacco Induced Diseases. 21(October). 1–9.
6.
Liang, Gui-Bin, Wenhua Wang, & Zhihui He. (2023). Sepsis associated with acute lung injury over the period 2012–2021: a bibliometric analysis. Frontiers in Physiology. 14. 1079736–1079736. 6 indexed citations
7.
Liang, Gui-Bin & Zhihui He. (2022). High Mobility Group Proteins in Sepsis. Frontiers in Immunology. 13. 911152–911152. 11 indexed citations
8.
Liang, Gui-Bin, et al.. (2022). Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis. Journal of Healthcare Engineering. 2022. 1–10. 10 indexed citations
9.
Liang, Gui-Bin, Zhihui He, Yan Chen, et al.. (2022). Existence of multiple organ aging in animal model ofemphysema induced by cigarette smoke extract. Tobacco Induced Diseases. 20(January). 1–11. 8 indexed citations
10.
11.
Liang, Gui-Bin, Min Gao, Wei Xing, et al.. (2022). lncRNA IGF2‐AS Regulates Nucleotide Metabolism by Mediating HMGA1 to Promote Pyroptosis of Endothelial Progenitor Cells in Sepsis Patients. Oxidative Medicine and Cellular Longevity. 2022(1). 9369035–9369035. 12 indexed citations
12.
He, Zhihui, et al.. (2021). p300/Sp1‐Mediated High Expression of p16 Promotes Endothelial Progenitor Cell Senescence Leading to the Occurrence of Chronic Obstructive Pulmonary Disease. Mediators of Inflammation. 2021(1). 5599364–5599364. 6 indexed citations
13.
He, Zhihui, Yan Chen, Ping Chen, et al.. (2021). Cigarette smoke extract affects methylation status and attenuates Sca-1 expression of mouse endothelial progenitor cell <i>in vitro</i>. Tobacco Induced Diseases. 19(January). 1–10. 3 indexed citations
14.
Liang, Gui-Bin, Jian-Hua Wei, Ri-Zhen Huang, et al.. (2020). Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA. European Journal of Medicinal Chemistry. 210. 112951–112951. 27 indexed citations
15.
Wei, Jian-Hua, Chenhui Yang, Gui-Bin Liang, et al.. (2020). Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents. Bioorganic & Medicinal Chemistry Letters. 30(8). 127051–127051. 12 indexed citations
16.
Liang, Gui-Bin, et al.. (2020). Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents. European Journal of Medicinal Chemistry. 188. 112033–112033. 20 indexed citations
17.
Huang, Ri-Zhen, Gui-Bin Liang, Yilin Fang, et al.. (2019). Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration. MedChemComm. 10(4). 584–597. 27 indexed citations
18.
Liang, Gui-Bin & Zhihui He. (2019). Animal models of emphysema. Chinese Medical Journal. 132(20). 2465–2475. 34 indexed citations
19.
Huang, Ri-Zhen, Gui-Bin Liang, Xiaochao Huang, et al.. (2017). Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation. European Journal of Medicinal Chemistry. 138. 979–992. 30 indexed citations
20.
Huang, Ri-Zhen, Bin Zhang, Xiaochao Huang, et al.. (2017). Synthesis and biological evaluation of terminal functionalized thiourea-containing dipeptides as antitumor agents. RSC Advances. 7(15). 8866–8878. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Letícia de Castro Barbosa Breakdown of academic impact, for papers by Altaf Ahmad Shah Breakdown of academic impact, for papers by Mervat M. Omran Breakdown of academic impact, for papers by Jinlian Wei Breakdown of academic impact, for papers by Mandava Bhuvan Tej Breakdown of academic impact, for papers by Yasumasa Sugita Breakdown of academic impact, for papers by Isabelle Solassol Breakdown of academic impact, for papers by Wen Sheng Tzeng Breakdown of academic impact, for papers by Jinxia Zhang Breakdown of academic impact, for papers by Venkataraman Srinivasan
Rankless by CCL
2026